Search by Drug Name or NDC
NDC 00069-5820-43 Tikosyn 0.5 mg/1 Details
Tikosyn 0.5 mg/1
Tikosyn is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Pfizer Laboratories Div Pfizer Inc. The primary component is DOFETILIDE.
MedlinePlus Drug Summary
Dofetilide is used to treat an irregular heartbeat (including atrial fibrillation or atrial flutter). It is in a class of medications called antiarrhythmics. It improves your heart rhythm by relaxing an overactive heart.
Related Packages: 00069-5820-43Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Dofetilide
Product Information
| NDC | 00069-5820 |
|---|---|
| Product ID | 0069-5820_a4df6111-f3d6-48d1-84d9-a7d4ee3175a3 |
| Associated GPIs | 35400025000130 |
| GCN Sequence Number | 044362 |
| GCN Sequence Number Description | dofetilide CAPSULE 500 MCG ORAL |
| HIC3 | A2A |
| HIC3 Description | ANTIARRHYTHMICS |
| GCN | 92307 |
| HICL Sequence Number | 020864 |
| HICL Sequence Number Description | DOFETILIDE |
| Brand/Generic | Brand |
| Proprietary Name | Tikosyn |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | dofetilide |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | CAPSULE |
| Route | ORAL |
| Active Ingredient Strength | 0.5 |
| Active Ingredient Units | mg/1 |
| Substance Name | DOFETILIDE |
| Labeler Name | Pfizer Laboratories Div Pfizer Inc |
| Pharmaceutical Class | Antiarrhythmic [EPC] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA020931 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00069-5820-43 (00069582043)
| NDC Package Code | 0069-5820-43 |
|---|---|
| Billing NDC | 00069582043 |
| Package | 40 BLISTER PACK in 1 CARTON (0069-5820-43) / 1 CAPSULE in 1 BLISTER PACK |
| Marketing Start Date | 1999-10-01 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 10.6644 |
| Pricing Unit | EA |
| Effective Date | 2024-01-01 |
| NDC Description | TIKOSYN 500 MCG CAPSULE |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 4 |
| Classification for Rate Setting | B |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis